Cite
HARVARD Citation
Limouris, G. et al. (2016). Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0, Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases. Clinical nuclear medicine. p. . [Online].